These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


419 related items for PubMed ID: 27708409

  • 1. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.
    Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS.
    Sci Rep; 2016 Oct 06; 6():34712. PubMed ID: 27708409
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul 06; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 3. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan 06; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 4. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease.
    Suryavanshi MV, Bhute SS, Gune RP, Shouche YS.
    Sci Rep; 2018 Nov 09; 8(1):16598. PubMed ID: 30413731
    [Abstract] [Full Text] [Related]

  • 5. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M.
    BJU Int; 2009 Jan 09; 103(1):18-21. PubMed ID: 19021605
    [Abstract] [Full Text] [Related]

  • 6. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB.
    J Am Soc Nephrol; 1999 Nov 09; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [Abstract] [Full Text] [Related]

  • 7. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr 09; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 8. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL.
    ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M.
    Med Princ Pract; 2003 Apr 06; 12(4):208-13. PubMed ID: 12966191
    [Abstract] [Full Text] [Related]

  • 11. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL, Moradi L, Paiste H, Wood KD, Assimos DG, Holmes RP, Nazzal L, Hatch M, Knight J.
    Appl Environ Microbiol; 2021 Aug 26; 87(18):e0054421. PubMed ID: 34190610
    [Abstract] [Full Text] [Related]

  • 12. Gut microbiome and kidney stone disease: not just an Oxalobacter story.
    Ticinesi A, Nouvenne A, Meschi T.
    Kidney Int; 2019 Jul 26; 96(1):25-27. PubMed ID: 31229040
    [Abstract] [Full Text] [Related]

  • 13. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR, Reid SJ.
    Adv Appl Microbiol; 2010 Jul 26; 72():63-87. PubMed ID: 20602988
    [Abstract] [Full Text] [Related]

  • 14. [Oxalate: a poorly soluble organic waste with consequences].
    Lu Y, Bonny O.
    Praxis (Bern 1994); 2015 Mar 25; 104(7):353-9. PubMed ID: 25804778
    [Abstract] [Full Text] [Related]

  • 15. Oxalobacter formigenes and its role in oxalate metabolism in the human gut.
    Stewart CS, Duncan SH, Cave DR.
    FEMS Microbiol Lett; 2004 Jan 15; 230(1):1-7. PubMed ID: 14734158
    [Abstract] [Full Text] [Related]

  • 16. [Oxalobacter formigenes - use of the colon microbiome in the prevention of kidney stones].
    Tarasewicz A, Laudańska E, Naumnik B.
    Pol Merkur Lekarski; 2022 Feb 22; 50(295):54-57. PubMed ID: 35278301
    [Abstract] [Full Text] [Related]

  • 17. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK, Hatch M.
    Surg Obes Relat Dis; 2017 Jul 22; 13(7):1152-1157. PubMed ID: 28552742
    [Abstract] [Full Text] [Related]

  • 18. The role of the microbiome in kidney stone formation.
    Mehta M, Goldfarb DS, Nazzal L.
    Int J Surg; 2016 Dec 22; 36(Pt D):607-612. PubMed ID: 27847292
    [Abstract] [Full Text] [Related]

  • 19. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells.
    Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H.
    Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773
    [Abstract] [Full Text] [Related]

  • 20. Stable expression of the oxc and frc genes from Oxalobacter formigenes in human embryo kidney 293 cells: implications for gene therapy of hyperoxaluria.
    Ye ZQ, Kong DB, Chen ZQ, Yao LF, Guo H, Yu X, Liu GL, Yang WM.
    Int J Mol Med; 2007 Oct 01; 20(4):521-6. PubMed ID: 17786282
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.